Antibody-targeted polymer-doxorubicin conjugates with pH-controlled activation. - Wikidata - wikimedia - TriplyDB

Antibody-targeted polymer-doxorubicin conjugates with pH-controlled activation.

Antibody-targeted polymer-doxorubicin conjugates with pH-controlled activation.

http://www.wikidata.org/entity/Q45204007

about

Traceless bioresponsive shielding of adenovirus hexon with HPMA copolymers maintains transduction capacity in vitro and in vivo Optical imaging-guided cancer therapy with fluorescent nanoparticles Synthesis of a covalent epirubicin-(C(3)-amide)-anti-HER2/neu immunochemotherapeutic utilizing a UV-photoactivated anthracycline intermediate Utilization of monoclonal antibody-targeted nanomaterials in the treatment of cancer.Epirubicin-[Anti-HER2/neu] Synthesized with an Epirubicin-(C13-imino)-EMCS Analog: Anti-Neoplastic Activity against Chemotherapeutic-Resistant SKBr-3 Mammary Carcinoma in Combination with Organic Selenium.Targeting of multidrug-resistant human ovarian carcinoma cells with anti-P-glycoprotein antibody conjugates.Antibody-cytotoxic agent conjugates for cancer therapy.Cellular delivery of doxorubicin via pH-controlled hydrazone linkage using multifunctional nano vehicle based on poly(β-l-malic acid)Recent advances in nanoparticle-based Förster resonance energy transfer for biosensing, molecular imaging and drug release profiling HPMA Copolymer-Drug Conjugates with Controlled Tumor-Specific Drug Release.Antibody-targeted biodegradable nanoparticles for cancer therapy.HPMA copolymer conjugates of DOX and mitomycin C for combination therapy: physicochemical characterization, cytotoxic effects, combination index analysis, and anti-tumor efficacy.RAFT-derived polymer-drug conjugates: poly(hydroxypropyl methacrylamide) (HPMA)-7-ethyl-10-hydroxycamptothecin (SN-38) conjugates.Peptide-targeted polyglutamic acid doxorubicin conjugates for the treatment of alpha(v)beta(6)-positive cancers.HPMA based macromolecular therapeutics: internalization, intracellular pathway and cell death depend on the character of covalent bond between the drug and the peptidic spacer and also on spacer composition.Core-shell poly(lactide-co-ε-caprolactone)-gelatin fiber scaffolds as pH-sensitive drug delivery systems.A tumor-targeted polymer theranostics platform for positron emission tomography and fluorescence imaging.

P2860

Q28539158-AC9FD491-D456-4728-9300-5F93EE36F5FC Q33731037-2DCFE5E2-0BD5-49C7-B0A6-20119282F9FE Q35180943-23260E0E-8E3C-4412-8F0F-4610DD69C47F Q35578037-A136AA76-A48D-4630-8B41-8A2A0A347B41 Q35896698-656B4E48-AB42-4065-8BE2-EF7425431D17 Q36185372-616C2394-313D-43DB-8868-70AC70D42E4A Q36316831-69E9E5F4-9820-4445-A191-C5A03AFCB417 Q36321843-22559777-915B-4D44-BA87-6081D6B9084D Q36538483-04855F25-6CD0-4A26-82C9-ADA5DF2FD076 Q38626421-B3A1D570-82CE-44F5-85D1-D51DDF341023 Q38665261-88CF1ECF-C9B7-43D8-82CC-A30B78BBD143 Q39096548-995A71C9-DFCA-4AFD-9D6D-83760AB09BB2 Q39432578-8739EBB1-552D-4BE2-8CDD-4753FE3543FF Q39949731-A2264633-2924-45AD-8BD2-10772E323BB5 Q40210611-D7BB87C1-146D-4359-A939-1F67ED402D45 Q47204191-8E4BAB9F-3D6B-413A-80B8-220A728A0E70 Q48088727-42601A80-94F0-45A6-8B28-57A0D028EAEC

P2860

Antibody-targeted polymer-doxorubicin conjugates with pH-controlled activation.

http://www.wikidata.org/entity/Q45204007

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Antibody-targeted polymer-doxorubicin conjugates with pH-controlled activation.

@en

Antibody-targeted polymer-doxorubicin conjugates with pH-controlled activation.

@nl

type

label

Antibody-targeted polymer-doxorubicin conjugates with pH-controlled activation.

@en

Antibody-targeted polymer-doxorubicin conjugates with pH-controlled activation.

@nl

prefLabel

Antibody-targeted polymer-doxorubicin conjugates with pH-controlled activation.

@en

Antibody-targeted polymer-doxorubicin conjugates with pH-controlled activation.

@nl

P1433

Q45204007-4E04F839-17B7-489C-8CCF-FD91A482A0C7

P1476

Q45204007-94088945-4A31-451D-9989-D55F3A63E792

P2093

Q45204007-5DE58975-5EAA-4791-B7AC-B682F13B8196

Q45204007-9F203B88-B26A-47DF-8E82-CABD938BC4AE

Q45204007-A500FA9C-E365-47A7-98F0-654BDDCDBF12

Q45204007-AE4B59DD-A3EC-499F-8387-13D4D117E5D0

Q45204007-BFED80D4-0005-4A4F-96FC-BA7B853DB81D

P2860

Q45204007-00748284-4B29-4ACE-A3D4-25384338E981

Q45204007-1C7DE11C-BB87-4F38-B878-BA50BD09FED7

Q45204007-31B1CCEA-92F0-4343-AF81-B992AD6957FD

Q45204007-3F073B98-00D6-4C0A-8745-D99FFF93B41E

Q45204007-4F6BE071-214F-4140-8872-29C5CF6192D0

Q45204007-56E8C7C6-C806-4D51-A2A0-2804F12CCA81

Q45204007-58BFD5FB-D390-4112-BBF9-4C7FC2FB99DB

Q45204007-6C241632-48D6-4313-86E5-926764AC5185

Q45204007-6C4E6DAC-880A-4E4C-B4DE-CC1DE7379C68

Q45204007-7A2629F6-9FD3-49CC-A586-F57C5C06448D

P304

Q45204007-21E54C9D-23E7-4F5D-BB0D-F4B51CAFA015

P31

Q45204007-D203B3F9-4E1D-4C64-8C12-AA44CA796389

P356

Q45204007-9551D1C1-118F-46CC-BA0A-10AEC09E011B

P433

Q45204007-E5FD4110-C81B-489D-96FF-8A56425925FF

P478

Q45204007-F501E4D1-BBC4-49B8-8B93-73AB1E4DD153

P577

Q45204007-57849D19-B195-4F09-9BA4-BB2D2B40FDC1

P698

Q45204007-6EAF3407-FA20-4EE8-B345-B63B5FE2F257

P921

Q45204007-0EBD71B8-CCC0-4AA3-8A16-890F022B317F

P356

10611860400011869

P1433

Journal of Drug Targeting

P1476

Antibody-targeted polymer-doxorubicin conjugates with pH-controlled activation.

@en

P2093

Chytil P

http://www.w3.org/2001/XMLSchema#string

Etrych T

http://www.w3.org/2001/XMLSchema#string

Jelínková M

http://www.w3.org/2001/XMLSchema#string

Ríhová B

http://www.w3.org/2001/XMLSchema#string

Ulbrich K

http://www.w3.org/2001/XMLSchema#string

P2860

Differences in the intracellular fate of free and polymer-bound doxorubicin.

Cytostatic and immunomobilizing activities of polymer-bound drugs: experimental and first clinical data.

Water soluble polymers in tumor targeted delivery.

Cytoplasmic delivery and nuclear targeting of synthetic macromolecules.

Clinical implications of N-(2-hydroxypropyl)methacrylamide copolymers.

Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia.

HPMA copolymers platinates containing dicarboxylato ligands. Preparation, characterisation and in vitro and in vivo evaluation.

Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes.

Antiproliferative effect of a lectin- and anti-Thy-1.2 antibody-targeted HPMA copolymer-bound doxorubicin on primary and metastatic human colorectal carcinoma and on human colorectal carcinoma transfected with the mouse Thy-1.2 gene.

New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties.

P304

477-489

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10611860400011869

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15621674

http://www.w3.org/2001/XMLSchema#string

P921